Adlai Nortye (ANL) Earnings Date & Reports

Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ANL is expected to report earnings to fall 4.69% to -61 cents per share on May 29

Q1'24

Est.

$-0.61

Q4'24

Missed

by $0.01

Q2'24

Beat

by $0.26

Q4'23

Est.

$-0.38

Q3'23

Est.

$-0.24

The last earnings report on April 30 showed earnings per share of -63 cents, missing the estimate of -62 cents. With 16.71K shares outstanding, the current market capitalization sits at 54.24M.

View a ticker or compare two or three

Compare

Interact to see
Advertisement

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

685 US Highway 1

Phone

+1 848 230-7430

Employees

N/A

Web

https://www.adlainortye.com